IGSF6 and carcinoma of esophagus: It was suggested that IGSF6 expression was increased in cancers such as bladder urothelial carcinoma (BLCA), esophageal carcinoma (ESCA), and glioblastoma multiforme (GBM), and was decreased in some others, particularly LUAD (Fig. 1A).